QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Zealand Pharma A/SDenmark1.11%May 19, 2026
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.63%July 3, 2026
Gubra A/SDenmark0.59%March 23, 2026
Lang & Schwarz AktiengesellschaftGermany0.59%February 2, 2022
Tubacex, S.A.Spain0.59%June 30, 2026
Medigene AGGermany0.55%December 4, 2017
Atos GroupFrance0.50%July 21, 2026

History of disclosures

6109 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
February 21, 2020BiocartisBelgium0.59%March 9, 2020
February 21, 2020Tecnicas Reunidas, S.A.Spain0.49%still open
February 21, 2020Stobart Group LTDUnited Kingdom0.48%still open
February 20, 2020VantivaFrance1.23%February 28, 2020
February 20, 2020Leovegas AB (publ)Sweden0.93%still open
February 20, 2020Oncopeptides ABSweden0.80%still open
February 20, 2020Kiadis Pharma N.V.Netherlands0.68%still open
February 20, 2020ErametFrance0.53%April 30, 2020
February 20, 2020Zealand Pharma A/SDenmark0.49%February 20, 2020
February 19, 2020VantivaFrance1.42%February 28, 2020
February 19, 2020Fingerprint Cards ABSweden0.85%still open
February 19, 2020Metro Bank PLCUnited Kingdom0.73%still open
February 19, 2020Kier Group PLCUnited Kingdom0.53%still open
February 19, 2020Eutelsat CommunicationsFrance0.45%February 21, 2020
February 18, 2020VantivaFrance1.27%February 28, 2020
February 18, 2020GenfitFrance1.07%November 9, 2020
February 18, 2020Leovegas AB (publ)Sweden0.83%still open
February 18, 2020Matas A/SDenmark0.59%February 18, 2020
February 18, 2020Tethys Oil ABSweden0.51%still open
February 17, 2020VantivaFrance1.18%February 28, 2020
February 17, 2020Kiadis Pharma N.V.Netherlands0.79%still open
February 17, 2020Leovegas AB (publ)Sweden0.79%still open
February 17, 2020Metro Bank PLCUnited Kingdom0.62%still open
February 14, 2020VantivaFrance1.20%February 28, 2020
February 14, 2020GenfitFrance1.18%November 9, 2020
February 14, 2020Fingerprint Cards ABSweden0.75%still open
February 14, 2020Evolution Services Sweden ABSweden0.71%still open
February 14, 2020Netent AB (publ)Sweden0.71%still open
February 14, 2020AMG Advanced Metallurgical Group N.V.Netherlands0.69%still open
February 14, 2020AMG Critical Materials N.V.Netherlands0.69%still open
February 14, 2020Leovegas AB (publ)Sweden0.69%still open
February 14, 2020Nokian RenkaatFinland0.59%still open
February 14, 2020Eutelsat CommunicationsFrance0.54%February 21, 2020
February 13, 2020Fingerprint Cards ABSweden0.92%still open
February 13, 2020Innate PharmaFrance0.78%June 4, 2020
February 13, 2020AMG Advanced Metallurgical Group N.V.Netherlands0.70%still open
February 13, 2020AMG Critical Materials N.V.Netherlands0.70%still open
February 13, 2020Catena Media P.L.CSweden0.70%still open
February 13, 2020BiocartisBelgium0.68%February 21, 2020
February 13, 2020Zealand Pharma A/SDenmark0.50%February 13, 2020
February 13, 2020Blue Prism Group PLCUnited Kingdom0.49%still open
February 13, 2020Bonava AB (publ)Sweden0.00%still open
February 12, 2020Leovegas AB (publ)Sweden0.79%still open
February 12, 2020Metro Bank PLCUnited Kingdom0.51%still open
February 12, 2020SAS ABSweden0.00%still open
February 11, 2020DBV TechnologiesFrance0.50%June 8, 2020
February 10, 2020Aurelius Equity Opportunities SE & CO. KGAAGermany1.24%still open
February 7, 2020Biesse SPAItaly0.79%still open
February 7, 2020Oncopeptides ABSweden0.79%still open
February 7, 2020Evolution Services Sweden ABSweden0.69%still open

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=101